Effect of Fluoxetine on treatment of adult amblyopic patients

Effect of Fluoxetine on treatment of amblyopia after critical period

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016052428046N1

Enrollment

Registered

2016-07-04

Start date

2013-04-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Amblyopia. Condition 2: amblyopia. Amblyopia Amblyopia

Interventions

Intervention 1: Fluoxetin, oral capsule, 0.50 mg/kg, onc a day, for 3 months. Intervention 2: Placebo,oral capsule,once a day, for 3 months.

Treatment - Drugs

Placebo

Fluoxetin, oral capsule, 0.50 mg/kg, onc a day, for 3 months

Placebo,oral capsule,once a day, for 3 months

Eligibility

Sex/Gender

All

Age

11 Years to 40 Years

Inclusion criteria

Inclusion criteria: moderate amblyopic patients without any effective eye or systemic disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Visual Acuity. Timepoint: monthly. Method of measurement: Snellen Chart.	—

Secondary

Measure	Time frame
Contrast Sensitivity. Timepoint: Monthly. Method of measurement: CSV1000.;Stereopsis. Timepoint: Monthly. Method of measurement: Fly-so.;Visual Evoked Potential. Timepoint: Monthly. Method of measurement: Rplland Consolt.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr karim Rastgar

Shiraz University of Medical Sciences

rastgark@gmail.com+98 71 3230 2026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 4, 2026